mosapride


SMILES CCOc1cc(N)c(cc1C(=O)NCC1OCCN(C1)Cc1ccc(cc1)F)Cl
InChIKey YPELFRMCRYSPKZ-UHFFFAOYSA-N

Chemical properties

Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 7
Molecular weight (Da) 421.2

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 8.17 8.17 8.17 Drug Central
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 6.72 6.72 6.72 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 8.18 8.18 8.18 Drug Central
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 6.68 6.68 6.68 ChEMBL
5-HT4 5HT4R Human 5-Hydroxytryptamine A pKi 8.16 8.16 8.16 Drug Central
5-HT4 5HT4R Human 5-Hydroxytryptamine A pKi 6.2 6.55 6.9 Guide to Pharmacology
α2A ADA2A Human Adrenoceptors A pKi 8.23 8.23 8.23 Drug Central
α2A ADA2A Human Adrenoceptors A pKi 5.86 5.86 5.86 ChEMBL
α2B ADA2B Human Adrenoceptors A pKi 8.22 8.22 8.22 Drug Central
α2B ADA2B Human Adrenoceptors A pKi 6.06 6.06 6.06 ChEMBL
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pIC50 6.53 6.53 6.53 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pIC50 6.4 6.4 6.4 ChEMBL
α2A ADA2A Human Adrenoceptors A pIC50 5.43 5.43 5.43 ChEMBL
α2B ADA2B Human Adrenoceptors A pIC50 5.72 5.72 5.72 ChEMBL